HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Construction of conditionally replicating adenovirus expressing staphylococcal enterotoxin A gene: potential usefulness for anti-tumor therapies.

AbstractOBJECTIVE:
The aim of this study was to construct a conditionally replicating adenovirus pPE3-SEA expressing staphylococcal enterotoxin A (SEA) gene.
MATERIALS AND METHODS:
A full-length SEA gene fragment was cloned into pENTR12 plasmid to obtain a recombinant viral plasmid pENTR12-SEA. The pENTR12-SEA plasmid was co-transfected into HEK293 cells along with pPE3-ccdB, which encoded for the virus backbone, to generate recombinant adenovirus pPE3-SEA vector. Amplified pPE3-SEA vectors were purified, and viral titer was determined using the 50% tissue culture infective dose method.
RESULTS:
The PCR, restriction enzyme digestion, and sequence analyses proved successful construction of replicating oncolytic adenovirus pENTR12-SEA and recombinant SEA expressing oncolytic adenovirus pPE3-SEA. The viral titer was 2.5 × 1010 pfu/ml.
CONCLUSIONS:
We successfully constructed conditionally replicating adenovirus pPE3-SEA which can be utilized for experimental studies of tumor-targeted therapies.
AuthorsP-Y Zhang, L Hao, Z-G Zhang, B-Z Dong, D Yang, X-L Wang, X-J Xuan, Z Yan, L Qing, Z-D Shi, D Liu, C-H Han
JournalEuropean review for medical and pharmacological sciences (Eur Rev Med Pharmacol Sci) Vol. 18 Issue 16 Pg. 2258-63 (Aug 2014) ISSN: 2284-0729 [Electronic] Italy
PMID25219823 (Publication Type: Journal Article)
Chemical References
  • Enterotoxins
  • enterotoxin A, Staphylococcal
Topics
  • Adenoviridae (genetics, physiology)
  • Enterotoxins (genetics)
  • Genetic Therapy
  • Genetic Vectors
  • HEK293 Cells
  • Humans
  • Neoplasms (therapy)
  • Transfection
  • Virus Replication

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: